Greg Russotti
Technology Chief & Manufacturing Officer Century Therapeutics
Greg Russotti is Chief Technology and Manufacturing Officer at Century Therapeutics. Prior to joining Century, Dr. Russotti served as Vice President of Cell Therapy Development and Operations at Celgene, where he guided chemistry, manufacturing and controls efforts for five cell therapy products into clinical development and helped establish in-house clinical and commercial CAR T manufacturing. Earlier, he held leadership roles at Merck Research Laboratories developing vaccines and monoclonal antibodies. He earned BS and MS degrees in Chemical Engineering from Rensselaer Polytechnic Institute and a PhD in Chemical and Biochemical Engineering from Rutgers University. He also holds academic and industry advisory roles at Rutgers and Georgia Tech.
Seminars
- Incorporating complex allogeneic edits as cell line development to reduce additional editing cycles
- Refining scale up readiness to accelerate timelines while protecting product quality and regulatory compliance
- Aligning with regulators on GMP editing component guidelines
- Establishing strategic manufacturing processes early to ensure phase one clarity, reduced rework and a scalable foundation for future growth
- Identifying optimal opportunities to optimize processes to improve manufacturing and trial outcomes
- Collaborating with flexible manufacturing partners to embed long term strategy from the beginning to support seamless scale up
